User profiles for Deepali Kumar
 | Deepali KumarUniversity Health Network Verified email at uhn.ca Cited by 20604 |
[HTML][HTML] Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients
A Third Vaccine Dose in Organ-Transplant Recipients It is known that people receiving
immune suppressive therapy, such as recipients of solid-organ transplants, have a suboptimal …
immune suppressive therapy, such as recipients of solid-organ transplants, have a suboptimal …
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. …
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. …
[HTML][HTML] COVID-19: a global transplant perspective on successfully navigating a pandemic
The COVID-19 pandemic has rapidly evolved and changed our way of life in an unprecedented
manner. The emergence of COVID-19 has impacted transplantation worldwide. The …
manner. The emergence of COVID-19 has impacted transplantation worldwide. The …
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
Cytomegalovirus (CMV) remains one of the most common infections after solid organ
transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management …
transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management …
[HTML][HTML] Coronavirus disease 2019: implications of emerging infections for transplantation
…, L Danziger-Isakov, EA Blumberg, D Kumar… - American Journal of …, 2020 - Elsevier
The recent identification of an outbreak of 2019- novel Coronavirus is currently evolving, and
the impact on transplantation is unknown. However, it is imperative that we anticipate the …
the impact on transplantation is unknown. However, it is imperative that we anticipate the …
[HTML][HTML] Anidulafungin versus fluconazole for invasive candidiasis
Background Anidulafungin, a new echinocandin, has potent activity against candida species.
We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority …
We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority …
The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most
common complications affecting solid organ transplant recipients, conveying higher risks of …
common complications affecting solid organ transplant recipients, conveying higher risks of …
[HTML][HTML] KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation
The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline
on the Evaluation and Management of Candidates for Kidney Transplantation is intended to …
on the Evaluation and Management of Candidates for Kidney Transplantation is intended to …
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
Background There are few data on the epidemiology and outcomes of influenza infection in
recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic …
recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic …
[HTML][HTML] Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
Background To date, only monoclonal antibodies have been shown to be effective for
outpatients with COVID-19. Interferon lambda-1 is a type III interferon involved in innate antiviral …
outpatients with COVID-19. Interferon lambda-1 is a type III interferon involved in innate antiviral …